Trial record 1 of 1 for:
UC-HNG-2007
Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers (PembroMetaRT)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04747054 |
Recruitment Status :
Recruiting
First Posted : February 10, 2021
Last Update Posted : October 13, 2023
|
Sponsor:
UNICANCER
Collaborators:
GORTEC
National Cancer Institute, France
Information provided by (Responsible Party):
UNICANCER
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Recruiting |
---|---|
Estimated Primary Completion Date : | October 1, 2025 |
Estimated Study Completion Date : | October 1, 2029 |